- Home
- BMRA vs IXHL Comparison
BMRA vs IXHL Comparison
Compare BMRA & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- IXHL
- Stock Information
- Founded
- BMRA 1971
- IXHL 2001
- Country
- BMRA United States
- IXHL Australia
- Employees
- BMRA N/A
- IXHL N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IXHL
- Sector
- BMRA Health Care
- IXHL
- Exchange
- BMRA Nasdaq
- IXHL Nasdaq
- Market Cap
- BMRA 11.2M
- IXHL 13.2M
- IPO Year
- BMRA N/A
- IXHL N/A
- Fundamental
- Price
- BMRA $0.57
- IXHL $0.64
- Analyst Decision
- BMRA
- IXHL
- Analyst Count
- BMRA 0
- IXHL 0
- Target Price
- BMRA N/A
- IXHL N/A
- AVG Volume (30 Days)
- BMRA 187.3K
- IXHL 61.4K
- Earning Date
- BMRA 04-11-2025
- IXHL 05-14-2025
- Dividend Yield
- BMRA N/A
- IXHL N/A
- EPS Growth
- BMRA N/A
- IXHL N/A
- EPS
- BMRA N/A
- IXHL N/A
- Revenue
- BMRA $5,578,000.00
- IXHL $98,000.00
- Revenue This Year
- BMRA N/A
- IXHL $3,817.06
- Revenue Next Year
- BMRA N/A
- IXHL $66.67
- P/E Ratio
- BMRA N/A
- IXHL N/A
- Revenue Growth
- BMRA 1.40
- IXHL N/A
- 52 Week Low
- BMRA $0.24
- IXHL $0.64
- 52 Week High
- BMRA $1.27
- IXHL $3.55
- Technical
- Relative Strength Index (RSI)
- BMRA 40.83
- IXHL 22.16
- Support Level
- BMRA $0.55
- IXHL $0.73
- Resistance Level
- BMRA $0.74
- IXHL $1.18
- Average True Range (ATR)
- BMRA 0.05
- IXHL 0.08
- MACD
- BMRA -0.01
- IXHL 0.02
- Stochastic Oscillator
- BMRA 9.84
- IXHL 1.74
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.